M3MTHRY +2.83%86 Days Payable is 116.35 as of Mar. 2026, which is 10% above its 10-year median of 105.74. GuruFocus rates MTHRY with a GF Score™ of 86/100 and a GF Value™ of $7.68 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 608 Healthcare Providers & Services companies, M3 ranks better than 72.37% on this metric.
M3's average Accounts Payable for the
three
months ended in Mar. 2026 was $362 Mil. M3's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $284 Mil.
Hence, M3's Days Payable for the
three
months ended in Mar. 2026 was 116.35.
The historical rank and industry rank for M3's Days Payable or its related term are showing as below:
MTHRY'
s Days Payable Range Over the Past 10 Years
Min: 81.41 Med: 105.74 Max: 133.12
Current: 111.38
During the past 13 years, M3's highest Days Payable was 133.12. The lowest was 81.41. And the median was 105.74.
MTHRY's Days Payable is ranked better than 72.37% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 58.08
vs MTHRY: 111.38
M3's Days Payable
increased
from Mar. 2025 (110.69) to Mar. 2026 (116.35).
It may suggest that M3delayed paying its suppliers.
M3 Days Payable Related Terms
M3 Days Payable Historical Data
* Premium members only.
The historical data trend for M3's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, M3's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M3 Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, M3's Days Payable distribution charts can be found below:
* The bar in red indicates where M3's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
M3's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M3 (MTHRY) has a Days Payable of 116.35 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on M3 and its competitors. This is 10% above median its historical median of 105.74. Over the past decade, M3's Days Payable has ranged from 81.41 to 133.12. According to the industry distribution chart, M3 ranks #168 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 27.6%.
Is M3's Days Payable too high?
M3's current Days Payable of 116.35 is 10% above median its 10-year median of 105.74. Over the past 10 years, this metric has ranged from a low of 81.41 to a high of 133.12. The Healthcare Providers & Services industry median Days Payable is 58.08. M3's value of 116.35 is 100.3% above this industry median. Based on the distribution chart, M3 ranks #168 out of 608 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, M3 has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does M3's Days Payable compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, M3 ranks #168 out of 608 companies for Days Payable. This puts M3 in the upper half of its industry. The industry median Days Payable is 58.08. M3's value of 116.35 is 100.3% above this benchmark. Historically, M3's own Days Payable has ranged from 81.41 to 133.12 over the past decade. While the company's 10-year median is 105.74 vs. the industry median of 58.08, M3 has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.08, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M3's current Days Payable of 116.35 is 100.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on M3 and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M3's current Days Payable is 116.35, which is 10% above median its own 10-year median of 105.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M3 stock overvalued right now?
Based on GuruFocus' analysis, M3 (MTHRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.68, compared to a current price of $5.45 — trading 29% below its estimated fair value. The current Days Payable is 116.35, which is 10% above median its 10-year median of 105.74 and 100.3% above the Healthcare Providers & Services industry median of 58.08. M3's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For M3 (MTHRY), the current Days Payable is 116.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M3 (MTHRY) Overvalued in 2026?
Based on GuruFocus' analysis, M3 stock appears to be undervalued.
The current stock price of $5.45 is trading 29% below its estimated GF Value™ of $7.68.
GuruFocus considers M3 to be Modestly Undervalued.
Key valuation signals for MTHRY:
Days Payable: 116.35 (10% above median its 10-year median of 105.74)
GF Value™: $7.68 vs. price of $5.45 (29% below fair value)
Industry Position: 100.3% above the Healthcare Providers & Services median (#168 of 608)
No single metric tells the full story. See the MTHRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
86GF Score
Get the complete analysis for MTHRY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MTHRY has been successfully added to your 
